{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:00:35Z","timestamp":1788091235590,"version":"build-2803163510"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12016-017-8652-1","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T18:15:59Z","timestamp":1509473759000},"page":"337-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review"],"prefix":"10.1007","volume":"53","author":[{"given":"Carlo","family":"Mainetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-5029","authenticated-orcid":false,"given":"Benedetta","family":"Terziroli Beretta-Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"key":"8652_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347. \nhttps:\/\/doi.org\/10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"8652_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407. \nhttps:\/\/doi.org\/10.1056\/NEJM197502202920807","journal-title":"N Engl J Med"},{"key":"8652_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR et al (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord NMD 14:337\u2013345. \nhttps:\/\/doi.org\/10.1016\/j.nmd.2004.02.006","journal-title":"Neuromuscul Disord NMD"},{"key":"8652_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay J-L et al (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84:231\u2013249","journal-title":"Medicine (Baltimore)"},{"key":"8652_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/B978-0-12-384929-8.00039-3","volume-title":"Autoimmune Dis","author":"L Casciola-Rosen","year":"2014","unstructured":"Casciola-Rosen L, Rosen A (2014) Chapter 39\u2014the autoimmune myopathies. In: Autoimmune Dis, 5th edn. Academic Press, Boston, pp 547\u2013554","edition":"5"},{"key":"8652_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/MD.0000000000000222","volume":"93","author":"Y Troyanov","year":"2014","unstructured":"Troyanov Y, Targoff IN, Payette M-P et al (2014) Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore) 93:318\u2013332. \nhttps:\/\/doi.org\/10.1097\/MD.0000000000000222","journal-title":"Medicine (Baltimore)"},{"key":"8652_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12016-015-8517-4","volume":"52","author":"I Cavazzana","year":"2017","unstructured":"Cavazzana I, Fredi M, Selmi C et al (2017) The clinical and histological spectrum of idiopathic inflammatory myopathies. Clin Rev Allergy Immunol 52:88\u201398. \nhttps:\/\/doi.org\/10.1007\/s12016-015-8517-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"8652_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","volume":"48\u201349","author":"L Iaccarino","year":"2014","unstructured":"Iaccarino L, Ghirardello A, Bettio S et al (2014) The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun 48\u201349:122\u2013127. \nhttps:\/\/doi.org\/10.1016\/j.jaut.2013.11.005","journal-title":"J Autoimmun"},{"key":"8652_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(03)14368-1","journal-title":"Lancet"},{"key":"8652_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.rdc.2013.06.001","volume":"39","author":"LG Rider","year":"2013","unstructured":"Rider LG, Katz JD, Jones OY (2013) Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin N Am 39:877\u2013904. \nhttps:\/\/doi.org\/10.1016\/j.rdc.2013.06.001","journal-title":"Rheum Dis Clin N Am"},{"key":"8652_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG, Shah M, Mamyrova G et al (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:223\u2013243. \nhttps:\/\/doi.org\/10.1097\/MD.0b013e31829d08f9","journal-title":"Medicine (Baltimore)"},{"key":"8652_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/rheumatology\/ket279","volume":"53","author":"P Venalis","year":"2014","unstructured":"Venalis P, Lundberg IE (2014) Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology Oxford 53:397\u2013405. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/ket279","journal-title":"Rheumatology Oxford"},{"key":"8652_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/B978-0-7020-4086-3.00032-1","volume":"119","author":"AJ Kooi van der","year":"2014","unstructured":"van der Kooi AJ, de Visser M (2014) Idiopathic inflammatory myopathies. Handb Clin Neurol 119:495\u2013512. \nhttps:\/\/doi.org\/10.1016\/B978-0-7020-4086-3.00032-1","journal-title":"Handb Clin Neurol"},{"key":"8652_CR14","doi-asserted-by":"publisher","first-page":"A330","DOI":"10.1016\/j.autrev.2009.11.006","volume":"9","author":"S Prieto","year":"2010","unstructured":"Prieto S, Grau JM (2010) The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 9:A330\u2013A334. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2009.11.006","journal-title":"Autoimmun Rev"},{"key":"8652_CR15","first-page":"1329","volume":"17","author":"CV Oddis","year":"1990","unstructured":"Oddis CV, Conte CG, Steen VD, Medsger TA (1990) Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 17:1329\u20131334","journal-title":"J Rheumatol"},{"key":"8652_CR16","first-page":"1198","volume":"25","author":"LM Pachman","year":"1998","unstructured":"Pachman LM, Hayford JR, Chung A et al (1998) Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 25:1198\u20131204","journal-title":"J Rheumatol"},{"key":"8652_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastaglia","year":"2002","unstructured":"Mastaglia FL, Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am 28:723\u2013741","journal-title":"Rheum Dis Clin N Am"},{"key":"8652_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mus.23302","volume":"45","author":"DE Furst","year":"2012","unstructured":"Furst DE, Amato AA, Iorga \u015eR et al (2012) Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve 45:676\u2013683. \nhttps:\/\/doi.org\/10.1002\/mus.23302","journal-title":"Muscle Nerve"},{"key":"8652_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1756-185X.2011.01669.x","volume":"16","author":"JA Tan","year":"2013","unstructured":"Tan JA, Roberts-Thomson PJ, Blumbergs P et al (2013) Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases. Int J Rheum Dis 16:331\u2013338. \nhttps:\/\/doi.org\/10.1111\/j.1756-185X.2011.01669.x","journal-title":"Int J Rheum Dis"},{"key":"8652_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/RHU.0b013e3182a21ba8","volume":"19","author":"J Rosa","year":"2013","unstructured":"Rosa J, Garrot LF, Navarta DA et al (2013) Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires. J Clin Rheumatol 19:303\u2013307. \nhttps:\/\/doi.org\/10.1097\/RHU.0b013e3182a21ba8","journal-title":"J Clin Rheumatol"},{"key":"8652_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","volume":"146","author":"MJ Bendewald","year":"2010","unstructured":"Bendewald MJ, Wetter DA, Li X, Davis MDP (2010) Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol 146:26\u201330. \nhttps:\/\/doi.org\/10.1001\/archdermatol.2009.328","journal-title":"Arch Dermatol"},{"key":"8652_CR22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00002281-200211000-00005","volume":"14","author":"AV Ramanan","year":"2002","unstructured":"Ramanan AV, Feldman BM (2002) Clinical outcomes in juvenile dermatomyositis. Curr Opin Rheumatol 14:658\u2013662","journal-title":"Curr Opin Rheumatol"},{"key":"8652_CR23","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/art.11090","volume":"48","author":"S Okada","year":"2003","unstructured":"Okada S, Weatherhead E, Targoff IN et al (2003) Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 48:2285\u20132293. \nhttps:\/\/doi.org\/10.1002\/art.11090","journal-title":"Arthritis Rheum"},{"key":"8652_CR24","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/art.37985","volume":"65","author":"M Shah","year":"2013","unstructured":"Shah M, Targoff IN, Rice MM et al (2013) Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum 65:1934\u20131941. \nhttps:\/\/doi.org\/10.1002\/art.37985","journal-title":"Arthritis Rheum"},{"key":"8652_CR25","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/art.1780291109","volume":"29","author":"ML Christensen","year":"1986","unstructured":"Christensen ML, Pachman LM, Schneiderman R et al (1986) Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29:1365\u20131370","journal-title":"Arthritis Rheum"},{"key":"8652_CR26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","volume":"137","author":"G Chevrel","year":"2003","unstructured":"Chevrel G, Page G, Granet C et al (2003) Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol 137:125\u2013133","journal-title":"J Neuroimmunol"},{"key":"8652_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0002-9440(10)63131-8","volume":"164","author":"G Page","year":"2004","unstructured":"Page G, Sattler A, Kersten S et al (2004) Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression. Am J Pathol 164:409\u2013417. \nhttps:\/\/doi.org\/10.1016\/S0002-9440(10)63131-8","journal-title":"Am J Pathol"},{"key":"8652_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","volume":"225","author":"A Waschbisch","year":"2010","unstructured":"Waschbisch A, Schwab N, Ruck T et al (2010) FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J Neuroimmunol 225:137\u2013142. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2010.03.013","journal-title":"J Neuroimmunol"},{"key":"8652_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/08916930802282651","volume":"42","author":"L Banica","year":"2009","unstructured":"Banica L, Besliu A, Pistol G et al (2009) Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 42:41\u201349. \nhttps:\/\/doi.org\/10.1080\/08916930802282651","journal-title":"Autoimmunity"},{"key":"8652_CR30","doi-asserted-by":"publisher","unstructured":"Thompson C, Piguet V, Choy E (2017) The pathogenesis of dermatomyositis. Br J Dermatol. \nhttps:\/\/doi.org\/10.1111\/bjd.15607","DOI":"10.1111\/bjd.15607"},{"key":"8652_CR31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/clinids\/18.2.166","volume":"18","author":"HW Horowitz","year":"1994","unstructured":"Horowitz HW, Sanghera K, Goldberg N et al (1994) Dermatomyositis associated with Lyme disease: case report and review of Lyme myositis. Clin Infect Dis 18:166\u2013171","journal-title":"Clin Infect Dis"},{"key":"8652_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A et al (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52:1\u201319. \nhttps:\/\/doi.org\/10.1007\/s12016-015-8510-y","journal-title":"Clin Rev Allergy Immunol"},{"key":"8652_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine TD (2005) Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 52:601\u2013607. \nhttps:\/\/doi.org\/10.1002\/art.20849","journal-title":"Arthritis Rheum"},{"key":"8652_CR34","first-page":"1009","volume":"27","author":"R Rios Fern\u00e1ndez","year":"2009","unstructured":"Rios Fern\u00e1ndez R, Callejas Rubio J-L, S\u00e1nchez Cano D et al (2009) Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature. Clin Exp Rheumatol 27:1009\u20131016","journal-title":"Clin Exp Rheumatol"},{"key":"8652_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","volume":"7","author":"M Zong","year":"2011","unstructured":"Zong M, Lundberg IE (2011) Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol 7:297\u2013306. \nhttps:\/\/doi.org\/10.1038\/nrrheum.2011.39","journal-title":"Nat Rev Rheumatol"},{"key":"8652_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12026-014-8588-y","volume":"61","author":"O Shovman","year":"2015","unstructured":"Shovman O, Agmon-Levin N, Gilburd B et al (2015) A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies. Immunol Res 61:135\u2013140. \nhttps:\/\/doi.org\/10.1007\/s12026-014-8588-y","journal-title":"Immunol Res"},{"key":"8652_CR37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nrrheum.2014.109","volume":"10","author":"SM Stanford","year":"2014","unstructured":"Stanford SM, Bottini N (2014) PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol 10:602\u2013611. \nhttps:\/\/doi.org\/10.1038\/nrrheum.2014.109","journal-title":"Nat Rev Rheumatol"},{"key":"8652_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2249.2000.01266.x","volume":"121","author":"LG Rider","year":"2000","unstructured":"Rider LG, Artlett CM, Foster CB et al (2000) Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol 121:47\u201352","journal-title":"Clin Exp Immunol"},{"key":"8652_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12016-016-8530-2","volume":"52","author":"S Moghadam-Kia","year":"2017","unstructured":"Moghadam-Kia S, Oddis CV, Aggarwal R (2017) Modern therapies for idiopathic inflammatory myopathies (IIMs): role of biologics. Clin Rev Allergy Immunol 52:81\u201387. \nhttps:\/\/doi.org\/10.1007\/s12016-016-8530-2","journal-title":"Clin Rev Allergy Immunol"},{"key":"8652_CR40","first-page":"69","volume-title":"Manif. Dermatol. Connect. Vasc. Affect. Syst\u00e9miques Apparent. Dermatol. M\u00e9decine","author":"C Franc\u00e8s","year":"2007","unstructured":"Franc\u00e8s C (2007) Dermatomyosite. In: Bessis D, Franc\u00e8s C, Guillot B, Guilhou J-J (eds) Manif. Dermatol. Connect. Vasc. Affect. Syst\u00e9miques Apparent. Dermatol. M\u00e9decine. Springer Paris, Paris, pp 69\u201383"},{"key":"8652_CR41","doi-asserted-by":"publisher","unstructured":"Callen JP (2010) Cutaneous manifestations of dermatomyositis and their management. Curr Rheumatol Rep 12:192\u2013197. \nhttps:\/\/doi.org\/10.1007\/s11926-010-0100-7","DOI":"10.1007\/s11926-010-0100-7"},{"key":"8652_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-015-8496-5","volume":"51","author":"Y Muro","year":"2016","unstructured":"Muro Y, Sugiura K, Akiyama M (2016) Cutaneous manifestations in dermatomyositis: key clinical and serological features\u2014a comprehensive review. Clin Rev Allergy Immunol 51:293\u2013302. \nhttps:\/\/doi.org\/10.1007\/s12016-015-8496-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"8652_CR43","unstructured":"Vleugels RA, Callen JP (2017) Dermatomyositis. In: Callen JP, Jorizzo JL, Zone JJ et al (eds) Dermatological signs of systemic disease. Elsevier Edinburg, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto, pp 13\u201321"},{"key":"8652_CR44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","volume":"20","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20:387\u2013408","journal-title":"Dermatol Clin"},{"key":"8652_CR45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00002281-200311000-00006","volume":"15","author":"B Santmyire-Rosenberger","year":"2003","unstructured":"Santmyire-Rosenberger B, Dugan EM (2003) Skin involvement in dermatomyositis. Curr Opin Rheumatol 15:714\u2013722","journal-title":"Curr Opin Rheumatol"},{"key":"8652_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","volume":"148","author":"SJ Balin","year":"2012","unstructured":"Balin SJ, Wetter DA, Andersen LK, Davis MDP (2012) Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009. Arch Dermatol 148:455\u2013462. \nhttps:\/\/doi.org\/10.1001\/archdermatol.2011.2052","journal-title":"Arch Dermatol"},{"key":"8652_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1529-8019.2010.01334.x","volume":"23","author":"CB Hansen","year":"2010","unstructured":"Hansen CB, Callen JP (2010) Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea\/scleroderma. Dermatol Ther 23:341\u2013349. \nhttps:\/\/doi.org\/10.1111\/j.1529-8019.2010.01334.x","journal-title":"Dermatol Ther"},{"key":"8652_CR48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","volume":"150","author":"A Valenzuela","year":"2014","unstructured":"Valenzuela A, Chung L, Casciola-Rosen L, Fiorentino D (2014) Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol 150:724\u2013729. \nhttps:\/\/doi.org\/10.1001\/jamadermatol.2013.10416","journal-title":"JAMA Dermatol"},{"key":"8652_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12016-016-8528-9","volume":"52","author":"L Cavagna","year":"2017","unstructured":"Cavagna L, Nu\u00f1o L, Scir\u00e8 CA et al (2017) Serum Jo-1 autoantibody and isolated arthritis in the antisynthetase syndrome: review of the literature and report of the experience of AENEAS collaborative group. Clin Rev Allergy Immunol 52:71\u201380. \nhttps:\/\/doi.org\/10.1007\/s12016-016-8528-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"8652_CR50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2230.1996.tb00151.x","volume":"21","author":"M Jara","year":"1996","unstructured":"Jara M, Am\u00e9rigo J, Duce S, Borbujo J (1996) Dermatomyositis and flagellate erythema. Clin Exp Dermatol 21:440\u2013441","journal-title":"Clin Exp Dermatol"},{"key":"8652_CR51","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1067\/mjd.2002.107491","volume":"46","author":"R Solans","year":"2002","unstructured":"Solans R, Cort\u00e9s J, Selva A et al (2002) Panniculitis: a cutaneous manifestation of dermatomyositis. J Am Acad Dermatol 46:S148\u2013S150","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1600-0714.2004.00280.x","volume":"34","author":"K M\u00e1rton","year":"2005","unstructured":"M\u00e1rton K, Hermann P, Dank\u00f3 K et al (2005) Evaluation of oral manifestations and masticatory force in patients with polymyositis and dermatomyositis. J Oral Pathol Med 34:164\u2013169. \nhttps:\/\/doi.org\/10.1111\/j.1600-0714.2004.00280.x","journal-title":"J Oral Pathol Med"},{"key":"8652_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-263X.2010.01074.x","volume":"21","author":"LM Gon\u00e7alves","year":"2011","unstructured":"Gon\u00e7alves LM, Bezerra-J\u00fanior JRS, Gord\u00f3n-N\u00fa\u00f1ez MA et al (2011) Oral manifestations as important symptoms for juvenile dermatomyositis early diagnosis: a case report. Int J Paediatr Dent 21:77\u201380. \nhttps:\/\/doi.org\/10.1111\/j.1365-263X.2010.01074.x","journal-title":"Int J Paediatr Dent"},{"key":"8652_CR54","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archderm.135.11.1370","volume":"135","author":"FE Ghali","year":"1999","unstructured":"Ghali FE, Stein LD, Fine JD et al (1999) Gingival telangiectases: an underappreciated physical sign of juvenile dermatomyositis. Arch Dermatol 135:1370\u20131374","journal-title":"Arch Dermatol"},{"key":"8652_CR55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/RHU.0000000000000377","volume":"22","author":"I Ward","year":"2016","unstructured":"Ward I, Hiles P, Arroyo R et al (2016) Digital pulp ulcerations and inverse Gottron papules in melanoma differentiation-associated gene 5-related dermatomyositis. J Clin Rheumatol 22:274\u2013275. \nhttps:\/\/doi.org\/10.1097\/RHU.0000000000000377","journal-title":"J Clin Rheumatol"},{"key":"8652_CR56","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1525-1470.2011.01585.x","volume":"29","author":"SD Quinter","year":"2012","unstructured":"Quinter SD, Chiu YE, Lyon VB et al (2012) Inverse Gottron\u2019s papules: an unusual cutaneous manifestation of juvenile dermatomyositis. Pediatr Dermatol 29:641\u2013644. \nhttps:\/\/doi.org\/10.1111\/j.1525-1470.2011.01585.x","journal-title":"Pediatr Dermatol"},{"key":"8652_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"D Fiorentino","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J et al (2011) The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 65:25\u201334. \nhttps:\/\/doi.org\/10.1016\/j.jaad.2010.09.016","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR58","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/acr.22498","volume":"67","author":"NS Narang","year":"2015","unstructured":"Narang NS, Casciola-Rosen L, Li S et al (2015) Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care Res 67:667\u2013672. \nhttps:\/\/doi.org\/10.1002\/acr.22498","journal-title":"Arthritis Care Res"},{"key":"8652_CR59","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2169\/internalmedicine.56.8343","volume":"56","author":"T Nagashima","year":"2017","unstructured":"Nagashima T, Nakamura J, Iwamoto M, Minota S (2017) Deep cutaneous ulcers in dermatomyositis. Intern Med 56:1749\u20131750. \nhttps:\/\/doi.org\/10.2169\/internalmedicine.56.8343","journal-title":"Intern Med"},{"key":"8652_CR60","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.annder.2013.04.083","volume":"140","author":"C Girard","year":"2013","unstructured":"Girard C, Vincent T, Bessis D (2013) Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case. Ann Dermatol Venereol 140:628\u2013634. \nhttps:\/\/doi.org\/10.1016\/j.annder.2013.04.083","journal-title":"Ann Dermatol Venereol"},{"key":"8652_CR61","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-017-3598-5","volume":"36","author":"JT Cox","year":"2017","unstructured":"Cox JT, Gullotti DM, Mecoli CA et al (2017) \u201cHiker\u2019s feet\u201d: a novel cutaneous finding in the inflammatory myopathies. Clin Rheumatol 36:1683\u20131686. \nhttps:\/\/doi.org\/10.1007\/s10067-017-3598-5","journal-title":"Clin Rheumatol"},{"key":"8652_CR62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2133.1994.tb08492.x","volume":"131","author":"WK Cheong","year":"1994","unstructured":"Cheong WK, Hughes GR, Norris PG, Hawk JL (1994) Cutaneous photosensitivity in dermatomyositis. Br J Dermatol 131:205\u2013208","journal-title":"Br J Dermatol"},{"key":"8652_CR63","unstructured":"Vleugels RA, Callen JP (2014) Dermatomyositis. In: Lebwohl MG, Berth-Jones J, Heymann WR et al (eds) Treatment of skin disease. Comprehensive therapeutic strategies. Elsevier Saunders, pp 183\u2013187"},{"key":"8652_CR64","first-page":"45","volume":"15","author":"LA Dourmishev","year":"2006","unstructured":"Dourmishev LA, Wollina U (2006) Dermatomyositis: immunopathologic study of skin lesions. Acta Dermatovenerol Alp Pannonica Adriat 15:45\u201351","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"8652_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0467-y","volume":"16","author":"MF Hoeltzel","year":"2014","unstructured":"Hoeltzel MF, Oberle EJ, Robinson AB et al (2014) The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis. Curr Rheumatol Rep 16:467. \nhttps:\/\/doi.org\/10.1007\/s11926-014-0467-y","journal-title":"Curr Rheumatol Rep"},{"key":"8652_CR66","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1699-258X(08)75546-3","volume":"4","author":"Z Morel Ayala","year":"2008","unstructured":"Morel Ayala Z, Mart\u00ednez Ram\u00edrez R, Mendieta Zer\u00f3n S et al (2008) Juvenile dermatomyositis and extensive calcinosis. Treatment with methylprednisolone and methotrexate. Reumatol Clin 4:248\u2013250. \nhttps:\/\/doi.org\/10.1016\/S1699-258X(08)75546-3","journal-title":"Reumatol Clin"},{"key":"8652_CR67","first-page":"809","volume":"22","author":"JT Lie","year":"1995","unstructured":"Lie JT (1995) Cardiac manifestations in polymyositis\/dermatomyositis: how to get to heart of the matter. J Rheumatol 22:809\u2013811","journal-title":"J Rheumatol"},{"key":"8652_CR68","first-page":"373","volume":"14","author":"L Gonzalez-Lopez","year":"1996","unstructured":"Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L et al (1996) Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 14:373\u2013379","journal-title":"Clin Exp Rheumatol"},{"key":"8652_CR69","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780221007","volume":"22","author":"CE Denbow","year":"1979","unstructured":"Denbow CE, Lie JT, Tancredi RG, Bunch TW (1979) Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 22:1088\u20131092","journal-title":"Arthritis Rheum"},{"key":"8652_CR70","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/rheumatology\/38.11.1153","volume":"38","author":"G Riemekasten","year":"1999","unstructured":"Riemekasten G, Opitz C, Audring H et al (1999) Beware of the heart: the multiple picture of cardiac involvement in myositis. Rheumatology Oxford 38:1153\u20131157","journal-title":"Rheumatology Oxford"},{"key":"8652_CR71","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0002-9149(78)90871-8","volume":"41","author":"JS Gottdiener","year":"1978","unstructured":"Gottdiener JS, Sherber HS, Hawley RJ, Engel WK (1978) Cardiac manifestations in polymyositis. Am J Cardiol 41:1141\u20131149","journal-title":"Am J Cardiol"},{"key":"8652_CR72","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1183\/16000617.00002015","volume":"24","author":"J-C Lega","year":"2015","unstructured":"Lega J-C, Reynaud Q, Belot A et al (2015) Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 24:216\u2013238. \nhttps:\/\/doi.org\/10.1183\/16000617.00002015","journal-title":"Eur Respir Rev"},{"key":"8652_CR73","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1183\/09031936.03.00026703","volume":"22","author":"V Cottin","year":"2003","unstructured":"Cottin V, Thivolet-B\u00e9jui F, Reynaud-Gaubert M et al (2003) Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 22:245\u2013250","journal-title":"Eur Respir J"},{"key":"8652_CR74","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","volume":"13","author":"J-C Lega","year":"2014","unstructured":"Lega J-C, Fabien N, Reynaud Q et al (2014) The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 13:883\u2013891. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2014.03.004","journal-title":"Autoimmun Rev"},{"key":"8652_CR75","first-page":"260","volume":"35","author":"S Hayashi","year":"2008","unstructured":"Hayashi S, Tanaka M, Kobayashi H et al (2008) High-resolution computed tomography characterization of interstitial lung diseases in polymyositis\/dermatomyositis. J Rheumatol 35:260\u2013269","journal-title":"J Rheumatol"},{"key":"8652_CR76","doi-asserted-by":"publisher","first-page":"e0154746","DOI":"10.1371\/journal.pone.0154746","volume":"11","author":"N Mugii","year":"2016","unstructured":"Mugii N, Hasegawa M, Matsushita T et al (2016) Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies. PLoS One 11:e0154746. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0154746","journal-title":"PLoS One"},{"key":"8652_CR77","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/rheumatology\/kem131","volume":"46","author":"LJ McCann","year":"2007","unstructured":"McCann LJ, Garay SM, Ryan MM et al (2007) Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores. Rheumatology Oxford 46:1363\u20131366. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kem131","journal-title":"Rheumatology Oxford"},{"key":"8652_CR78","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12016-015-8512-9","volume":"52","author":"I Pagnini","year":"2017","unstructured":"Pagnini I, Vitale A, Selmi C et al (2017) Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms. Clin Rev Allergy Immunol 52:34\u201344. \nhttps:\/\/doi.org\/10.1007\/s12016-015-8512-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"8652_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-95","volume":"11","author":"A Kronbichler","year":"2013","unstructured":"Kronbichler A, Mayer G (2013) Renal involvement in autoimmune connective tissue diseases. BMC Med 11:95. \nhttps:\/\/doi.org\/10.1186\/1741-7015-11-95","journal-title":"BMC Med"},{"key":"8652_CR80","first-page":"207","volume":"28","author":"M Regan","year":"2001","unstructured":"Regan M, Haque U, Pomper M et al (2001) Central nervous system vasculitis as a complication of refractory dermatomyositis. J Rheumatol 28:207\u2013211","journal-title":"J Rheumatol"},{"key":"8652_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/088307389400900315","volume":"9","author":"C Jimenez","year":"1994","unstructured":"Jimenez C, Rowe PC, Keene D (1994) Cardiac and central nervous system vasculitis in a child with dermatomyositis. J Child Neurol 9:297\u2013300. \nhttps:\/\/doi.org\/10.1177\/088307389400900315","journal-title":"J Child Neurol"},{"key":"8652_CR82","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.rbr.2014.10.001","volume":"55","author":"LS Missumi","year":"2015","unstructured":"Missumi LS, de Souza FHC, Andrade JQ, Shinjo SK (2015) Pregnancy outcomes in dermatomyositis and polymyositis patients. Rev Bras Reumatol 55:95\u2013102. \nhttps:\/\/doi.org\/10.1016\/j.rbr.2014.10.001","journal-title":"Rev Bras Reumatol"},{"key":"8652_CR83","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.semarthrit.2014.05.004","volume":"44","author":"I Pinal-Fernandez","year":"2014","unstructured":"Pinal-Fernandez I, Selva-O\u2019Callaghan A, Fernandez-Codina A et al (2014) \u201cPregnancy in adult-onset idiopathic inflammatory myopathy\u201d: report from a cohort of myositis patients from a single center. Semin Arthritis Rheum 44:234\u2013240. \nhttps:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.004","journal-title":"Semin Arthritis Rheum"},{"key":"8652_CR84","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1002\/art.39311","volume":"67","author":"JS Chen","year":"2015","unstructured":"Chen JS, Roberts CL, Simpson JM, March LM (2015) Pregnancy outcomes in women with rare autoimmune diseases. Arthritis Rheumatol 67:3314\u20133323. \nhttps:\/\/doi.org\/10.1002\/art.39311","journal-title":"Arthritis Rheumatol"},{"key":"8652_CR85","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","volume":"23","author":"BT Beretta-Piccoli","year":"2017","unstructured":"Beretta-Piccoli BT, Mieli-Vergani G, Vergani D (2017) Autoimmune hepatitis: standard treatment and systematic review of alternative treatments. World J Gastroenterol 23:6030\u20136048. \nhttps:\/\/doi.org\/10.3748\/wjg.v23.i33.6030","journal-title":"World J Gastroenterol"},{"key":"8652_CR86","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3109\/14397595.2014.975906","volume":"27","author":"M Ochiai","year":"2017","unstructured":"Ochiai M, Sato E, Tanaka E et al (2017) Successful delivery in a patient with clinically amyopathic dermatomyositis during pregnancy despite first-trimester acute exacerbation of interstitial lung disease. Mod Rheumatol 27:364\u2013368. \nhttps:\/\/doi.org\/10.3109\/14397595.2014.975906","journal-title":"Mod Rheumatol"},{"key":"8652_CR87","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jaad.2004.05.024","volume":"51","author":"K Morihara","year":"2004","unstructured":"Morihara K, Katoh N, Hirano S, Kishimoto S (2004) Amyopathic dermatomyositis presenting during pregnancy. J Am Acad Dermatol 51:838\u2013840. \nhttps:\/\/doi.org\/10.1016\/j.jaad.2004.05.024","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR88","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0190-9622(91)70153-S","volume":"24","author":"RL Euwer","year":"1991","unstructured":"Euwer RL, Sontheimer RD (1991) Amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 24:959\u2013966","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR89","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0025-7125(16)31343-8","volume":"61","author":"CM Pearson","year":"1977","unstructured":"Pearson CM, Bohan A (1977) The spectrum of polymyositis and dermatomyositis. Med Clin North Am 61:439\u2013457","journal-title":"Med Clin North Am"},{"key":"8652_CR90","first-page":"128","volume":"31","author":"E Ghazi","year":"2013","unstructured":"Ghazi E, Sontheimer RD, Werth VP (2013) The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Clin Exp Rheumatol 31:128\u2013134","journal-title":"Clin Exp Rheumatol"},{"key":"8652_CR91","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/archdermatol.2010.134","volume":"146","author":"PA Morganroth","year":"2010","unstructured":"Morganroth PA, Kreider ME, Okawa J et al (2010) Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. Arch Dermatol 146:729\u2013738. \nhttps:\/\/doi.org\/10.1001\/archdermatol.2010.134","journal-title":"Arch Dermatol"},{"key":"8652_CR92","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","volume":"54","author":"P Gerami","year":"2006","unstructured":"Gerami P, Schope JM, McDonald L et al (2006) A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 54:597\u2013613. \nhttps:\/\/doi.org\/10.1016\/j.jaad.2005.10.041","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR93","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626\u2013636","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR94","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-84-1-68","volume":"84","author":"BE Barnes","year":"1976","unstructured":"Barnes BE, Mawr B (1976) Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 84:68\u201376","journal-title":"Ann Intern Med"},{"key":"8652_CR95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00051675","volume":"6","author":"WH Chow","year":"1995","unstructured":"Chow WH, Gridley G, Mellemkjaer L et al (1995) Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control CCC 6:9\u201313","journal-title":"Cancer Causes Control CCC"},{"key":"8652_CR96","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","volume":"134","author":"R Buchbinder","year":"2001","unstructured":"Buchbinder R, Forbes A, Hall S et al (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134:1087\u20131095","journal-title":"Ann Intern Med"},{"key":"8652_CR97","first-page":"615","volume":"32","author":"D Chen","year":"2014","unstructured":"Chen D, Yuan S, Wu X et al (2014) Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China. Clin Exp Rheumatol 32:615\u2013621","journal-title":"Clin Exp Rheumatol"},{"key":"8652_CR98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","volume":"85","author":"D Stockton","year":"2001","unstructured":"Stockton D, Doherty VR, Brewster DH (2001) Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85:41\u201345. \nhttps:\/\/doi.org\/10.1054\/bjoc.2001.1699","journal-title":"Br J Cancer"},{"key":"8652_CR99","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson B, Lindel\u00f6f B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326:363\u2013367. \nhttps:\/\/doi.org\/10.1056\/NEJM199202063260602","journal-title":"N Engl J Med"},{"key":"8652_CR100","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40257-015-0120-1","volume":"16","author":"JM Olazagasti","year":"2015","unstructured":"Olazagasti JM, Baez PJ, Wetter DA, Ernste FC (2015) Cancer risk in dermatomyositis: a meta-analysis of cohort studies. Am J Clin Dermatol 16:89\u201398. \nhttps:\/\/doi.org\/10.1007\/s40257-015-0120-1","journal-title":"Am J Clin Dermatol"},{"key":"8652_CR101","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","volume":"165","author":"C-F Kuo","year":"2011","unstructured":"Kuo C-F, See L-C, K-H Y et al (2011) Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol 165:1273\u20131279. \nhttps:\/\/doi.org\/10.1111\/j.1365-2133.2011.10595.x","journal-title":"Br J Dermatol"},{"key":"8652_CR102","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10165-010-0362-y","volume":"21","author":"K Azuma","year":"2011","unstructured":"Azuma K, Yamada H, Ohkubo M et al (2011) Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol 21:178\u2013183. \nhttps:\/\/doi.org\/10.1007\/s10165-010-0362-y","journal-title":"Mod Rheumatol"},{"key":"8652_CR103","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-012-0310-2","volume":"15","author":"ML Mannion","year":"2013","unstructured":"Mannion ML, Beukelman T (2013) What is the background incidence of malignancy in children with rheumatic disease? Curr Rheumatol Rep 15:310. \nhttps:\/\/doi.org\/10.1007\/s11926-012-0310-2","journal-title":"Curr Rheumatol Rep"},{"key":"8652_CR104","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","volume":"32","author":"P Morris","year":"2010","unstructured":"Morris P, Dare J (2010) Juvenile dermatomyositis as a paraneoplastic phenomenon: an update. J Pediatr Hematol Oncol 32:189\u2013191. \nhttps:\/\/doi.org\/10.1097\/MPH.0b013e3181bf29a2","journal-title":"J Pediatr Hematol Oncol"},{"key":"8652_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094128","volume":"9","author":"X Lu","year":"2014","unstructured":"Lu X, Yang H, Shu X et al (2014) Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis. PLoS One 9:e94128. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0094128","journal-title":"PLoS One"},{"key":"8652_CR106","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ad.2013.11.007","volume":"105","author":"C Requena","year":"2014","unstructured":"Requena C, Alfaro A, Traves V et al (2014) Paraneoplastic dermatomyositis: a study of 12 cases. Actas Dermosifiliogr 105:675\u2013682. \nhttps:\/\/doi.org\/10.1016\/j.ad.2013.11.007","journal-title":"Actas Dermosifiliogr"},{"key":"8652_CR107","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","volume":"14","author":"Z Amoura","year":"2005","unstructured":"Amoura Z, Duhaut P, Huong DLT et al (2005) Tumor antigen markers for the detection of solid cancers in inflammatory myopathies. Cancer Epidemiol Biomark Prev 14:1279\u20131282. \nhttps:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0624","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"8652_CR108","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ddg.12909","volume":"14","author":"C Sunderk\u00f6tter","year":"2016","unstructured":"Sunderk\u00f6tter C, Nast A, Worm M et al (2016) Guidelines on dermatomyositis\u2014excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 14:321\u2013338. \nhttps:\/\/doi.org\/10.1111\/ddg.12909","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"key":"8652_CR109","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00128071-200607060-00002","volume":"7","author":"RD Quain","year":"2006","unstructured":"Quain RD, Werth VP (2006) Management of cutaneous dermatomyositis: current therapeutic options. Am J Clin Dermatol 7:341\u2013351","journal-title":"Am J Clin Dermatol"},{"key":"8652_CR110","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","volume":"10","author":"TY Woo","year":"1984","unstructured":"Woo TY, Callen JP, Voorhees JJ et al (1984) Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 10:592\u2013600. \nhttps:\/\/doi.org\/10.1016\/S0190-9622(84)80263-7","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR111","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/archderm.141.7.855","volume":"141","author":"GC Ang","year":"2005","unstructured":"Ang GC, Werth VP (2005) Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study. Arch Dermatol 141:855\u2013859. \nhttps:\/\/doi.org\/10.1001\/archderm.141.7.855","journal-title":"Arch Dermatol"},{"key":"8652_CR112","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jaad.2017.03.027","volume":"77","author":"L Mittal","year":"2017","unstructured":"Mittal L, Werth VP (2017) The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis. J Am Acad Dermatol 77:374\u2013377. \nhttps:\/\/doi.org\/10.1016\/j.jaad.2017.03.027","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR113","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/09541440042000269","volume":"15","author":"CB Hollar","year":"2004","unstructured":"Hollar CB, Jorizzo JL (2004) Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study. J Dermatol Treat 15:35\u201339. \nhttps:\/\/doi.org\/10.1080\/09541440042000269","journal-title":"J Dermatol Treat"},{"key":"8652_CR114","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993\u20132000. \nhttps:\/\/doi.org\/10.1056\/NEJM199312303292704","journal-title":"N Engl J Med"},{"key":"8652_CR115","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1212\/WNL.51.6_Suppl_5.S37","volume":"51","author":"MC Dalakas","year":"1998","unstructured":"Dalakas MC (1998) Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology 51:S37\u2013S45","journal-title":"Neurology"},{"key":"8652_CR116","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1136\/ard.2011.153718","volume":"70","author":"CG Lam","year":"2011","unstructured":"Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM (2011) Efficacy of intravenous Ig therapy in juvenile dermatomyositis. Ann Rheum Dis 70:2089\u20132094. \nhttps:\/\/doi.org\/10.1136\/ard.2011.153718","journal-title":"Ann Rheum Dis"},{"key":"8652_CR117","doi-asserted-by":"publisher","unstructured":"Dourmishev LA, Guleva DV, Miteva LG (2017) Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology. Wien Med Wochenschr 1946. \nhttps:\/\/doi.org\/10.1007\/s10354-017-0595-x","DOI":"10.1007\/s10354-017-0595-x"},{"key":"8652_CR118","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1529-0131(200012)13:6<360::AID-ART5>3.0.CO;2-Q","volume":"13","author":"MS Klein-Gitelman","year":"2000","unstructured":"Klein-Gitelman MS, Waters T, Pachman LM (2000) The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis. Arthritis Care Res 13:360\u2013368","journal-title":"Arthritis Care Res"},{"key":"8652_CR119","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.rdc.2015.08.011","volume":"42","author":"A Postolova","year":"2016","unstructured":"Postolova A, Chen JK, Chung L (2016) Corticosteroids in myositis and scleroderma. Rheum Dis Clin N Am 42:103\u2013118, ix. \nhttps:\/\/doi.org\/10.1016\/j.rdc.2015.08.011","journal-title":"Rheum Dis Clin N Am"},{"key":"8652_CR120","doi-asserted-by":"publisher","unstructured":"Griger Z, Nagy-Vincze M, Dank\u00f3 K (2017) Pharmacological management of dermatomyositis. Expert Rev Clin Pharmacol:1\u201310. \nhttps:\/\/doi.org\/10.1080\/17512433.2017.1353910","DOI":"10.1080\/17512433.2017.1353910"},{"key":"8652_CR121","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-4615-4857-7_54","volume":"455","author":"HD Bolosiu","year":"1999","unstructured":"Bolosiu HD, Man L, Rednic S (1999) The effect of methylprednisolone pulse therapy in polymyositis\/dermatomyositis. Adv Exp Med Biol 455:349\u2013357","journal-title":"Adv Exp Med Biol"},{"key":"8652_CR122","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0190-9622(96)90037-7","volume":"34","author":"LA Drake","year":"1996","unstructured":"Drake LA, Dinehart SM, Farmer ER et al (1996) Guidelines of care for dermatomyositis. American Academy of Dermatology. J Am Acad Dermatol 34:824\u2013829","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR123","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","volume":"387","author":"N Ruperto","year":"2016","unstructured":"Ruperto N, Pistorio A, Oliveira S et al (2016) Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet 387:671\u2013678. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(15)01021-1","journal-title":"Lancet"},{"key":"8652_CR124","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","volume":"94","author":"MM Joffe","year":"1993","unstructured":"Joffe MM, Love LA, Leff RL et al (1993) Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 94:379\u2013387","journal-title":"Am J Med"},{"key":"8652_CR125","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jaad.2013.01.008","volume":"68","author":"JW Click","year":"2013","unstructured":"Click JW, Qureshi AA, Vleugels RA (2013) Methotrexate for the treatment of cutaneous dermatomyositis. J Am Acad Dermatol 68:1043\u20131045. \nhttps:\/\/doi.org\/10.1016\/j.jaad.2013.01.008","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR126","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/ar3704","volume":"14","author":"E Schiopu","year":"2012","unstructured":"Schiopu E, Phillips K, MacDonald PM et al (2012) Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther 14:R22. \nhttps:\/\/doi.org\/10.1186\/ar3704","journal-title":"Arthritis Res Ther"},{"key":"8652_CR127","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/acr.20212","volume":"62","author":"PA Morganroth","year":"2010","unstructured":"Morganroth PA, Kreider ME, Werth VP (2010) Mycophenolate mofetil for interstitial lung disease in dermatomyositis. Arthritis Care Res 62:1496\u20131501. \nhttps:\/\/doi.org\/10.1002\/acr.20212","journal-title":"Arthritis Care Res"},{"key":"8652_CR128","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/acr.20269","volume":"62","author":"KA Rouster-Stevens","year":"2010","unstructured":"Rouster-Stevens KA, Morgan GA, Wang D, Pachman LM (2010) Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis. Arthritis Care Res 62:1446\u20131451. \nhttps:\/\/doi.org\/10.1002\/acr.20269","journal-title":"Arthritis Care Res"},{"key":"8652_CR129","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3109\/08923973.2013.833624","volume":"35","author":"E Cozzani","year":"2013","unstructured":"Cozzani E, Cinotti E, Felletti R et al (2013) Amyopathic dermatomyositis with lung involvement responsive to mycophenolate mofetil. Immunopharmacol Immunotoxicol 35:687\u2013692. \nhttps:\/\/doi.org\/10.3109\/08923973.2013.833624","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"8652_CR130","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/1756-185X.12931","volume":"19","author":"K-I Ueno","year":"2016","unstructured":"Ueno K-I, Shimojima Y, Kishida D et al (2016) Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis. Int J Rheum Dis 19:1322\u20131330. \nhttps:\/\/doi.org\/10.1111\/1756-185X.12931","journal-title":"Int J Rheum Dis"},{"key":"8652_CR131","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12016-016-8582-3","volume":"52","author":"CB Chighizola","year":"2017","unstructured":"Chighizola CB, Ong VH, Meroni PL (2017) The use of cyclosporine a in rheumatology: a 2016 comprehensive review. Clin Rev Allergy Immunol 52:401\u2013423. \nhttps:\/\/doi.org\/10.1007\/s12016-016-8582-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"8652_CR132","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/CND.0b013e31828ee913","volume":"14","author":"M Nagappa","year":"2013","unstructured":"Nagappa M, Taly AB, Sinha S et al (2013) Efficacy and limitations of pulse cyclophosphamide therapy in polymyositis and dermatomyositis. J Clin Neuromuscul Dis 14:161\u2013168. \nhttps:\/\/doi.org\/10.1097\/CND.0b013e31828ee913","journal-title":"J Clin Neuromuscul Dis"},{"key":"8652_CR133","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archderm.143.6.763","volume":"143","author":"L Chung","year":"2007","unstructured":"Chung L, Genovese MC, Fiorentino DF (2007) A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 143:763\u2013767. \nhttps:\/\/doi.org\/10.1001\/archderm.143.6.763","journal-title":"Arch Dermatol"},{"key":"8652_CR134","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/rheumatology\/ker088","volume":"50","author":"EAM Mahler","year":"2011","unstructured":"Mahler EAM, Blom M, Voermans NC et al (2011) Rituximab treatment in patients with refractory inflammatory myopathies. Rheumatology Oxford 50:2206\u20132213. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/ker088","journal-title":"Rheumatology Oxford"},{"key":"8652_CR135","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314\u2013324. \nhttps:\/\/doi.org\/10.1002\/art.37754","journal-title":"Arthritis Rheum"},{"key":"8652_CR136","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.22477","volume":"70","author":"Muscle Study Group","year":"2011","unstructured":"Muscle Study Group (2011) A randomized, pilot trial of etanercept in dermatomyositis. Ann Neurol 70:427\u2013436. \nhttps:\/\/doi.org\/10.1002\/ana.22477","journal-title":"Ann Neurol"},{"key":"8652_CR137","doi-asserted-by":"crossref","first-page":"h1269","DOI":"10.1136\/bmj.h1269","volume":"350","author":"R Conway","year":"2015","unstructured":"Conway R, Low C, Coughlan RJ et al (2015) Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials. BMJ 350:h1269","journal-title":"BMJ"},{"key":"8652_CR138","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","volume":"47","author":"RE Fisler","year":"2002","unstructured":"Fisler RE, Liang MG, Fuhlbrigge RC et al (2002) Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 47:505\u2013511","journal-title":"J Am Acad Dermatol"},{"key":"8652_CR139","first-page":"303","volume":"35","author":"M Fredi","year":"2017","unstructured":"Fredi M, Bartoli F, Cavazzana I et al (2017) Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options. Clin Exp Rheumatol 35:303\u2013308","journal-title":"Clin Exp Rheumatol"},{"key":"8652_CR140","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"FB Enders","year":"2017","unstructured":"Enders FB, Bader-Meunier B, Baildam E et al (2017) Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis 76:329\u2013340. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-209247","journal-title":"Ann Rheum Dis"},{"key":"8652_CR141","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/rheumatology\/keu484","volume":"54","author":"T Ruck","year":"2015","unstructured":"Ruck T, Bittner S, Kuhlmann T et al (2015) Long-term efficacy of alemtuzumab in polymyositis. Rheumatology Oxford 54:560\u2013562. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/keu484","journal-title":"Rheumatology Oxford"},{"key":"8652_CR142","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3899\/jrheum.080972","volume":"35","author":"B Thompson","year":"2008","unstructured":"Thompson B, Corris P, Miller JAL et al (2008) Alemtuzumab (Campath-1H) for treatment of refractory polymyositis. J Rheumatol 35:2080\u20132082","journal-title":"J Rheumatol"},{"key":"8652_CR143","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","volume":"160","author":"B Arabshahi","year":"2012","unstructured":"Arabshahi B, Silverman RA, Jones OY, Rider LG (2012) Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis. J Pediatr 160:520\u2013522. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2011.11.057","journal-title":"J Pediatr"},{"key":"8652_CR144","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","volume":"73","author":"BW Higgs","year":"2014","unstructured":"Higgs BW, Zhu W, Morehouse C et al (2014) A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-\u03b1 monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients. Ann Rheum Dis 73:256\u2013262. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2012-202794","journal-title":"Ann Rheum Dis"},{"key":"8652_CR145","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/rheumatology\/ket413","volume":"53","author":"X Guo","year":"2014","unstructured":"Guo X, Higgs BW, Rebelatto M et al (2014) Suppression of soluble T cell-associated proteins by an anti-interferon-\u03b1 monoclonal antibody in adult patients with dermatomyositis or polymyositis. Rheumatology Oxford 53:686\u2013695. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/ket413","journal-title":"Rheumatology Oxford"},{"key":"8652_CR146","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1136\/ard.2010.141804","volume":"70","author":"D Wang","year":"2011","unstructured":"Wang D, Zhang H, Cao M et al (2011) Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. Ann Rheum Dis 70:1285\u20131288. \nhttps:\/\/doi.org\/10.1136\/ard.2010.141804","journal-title":"Ann Rheum Dis"},{"key":"8652_CR147","doi-asserted-by":"publisher","unstructured":"Choudhary MM, Hajj-Ali RA, Lowder CY (2014) Gender and ocular manifestations of connective tissue diseases and systemic vasculitides J Ophthalmol 2014:403042. \nhttps:\/\/doi.org\/10.1155\/2014\/403042","DOI":"10.1155\/2014\/403042"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8652-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T23:12:00Z","timestamp":1511219520000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8652-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":147,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["8652"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8652-1","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]}}}